Right. But the board of private companies can entertain buy outs. InCelldx is very attractive opportunity for large diagnostics which are consolidating their business objectives, cheaper than spending on their own R&D. Bruce continues to increase the value of his company by developing assays in record time and acquiring contracts frequently.

As a private company he can spend time what he does best, science. Not dealing with shareholders.